• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

A Chinese EV startup wants to build a ridable robot unicorn for kids

September 8, 2021 by David Barret Leave a Comment

Never mind buying a robot dog for your kids — you might just get them a mythical creature instead. Chinese EV maker Xpeng has teased a robot unicorn meant for children to ride. As SCMP notes, the quadruped will take advantage of Xpeng’s experiences with autonomous driving and other AI tasks to navigate multiple terrain types, recognize objects and provide “emotional interaction.”

The company is shy on most other details, although the design looks and trots like a cuter, more kid-friendly version of Boston Robotics’ Spot. It’s appropriately about as tall as a child. Sorry, folks, you won’t prance your way to work.

This robot unicorn is just about as mythical as the ‘real’ thing, too. Xpeng hasn’t revealed when it expects to deliver its robotic horse-with-a-horn, let alone pricing or availability. It might not cost as much as a $75,000 Spot, but we’d expect something this sophisticated to cost more than the $2,900 Aibo from 2019.

To some extent, profit is beside the point. Xpeng chief He Xiaopeng said the unicorn was part of a broader move into the robotics space by taking advantage of the company’s existing technology. Think of this as a first step. What Xpeng learns from its unicorn could lead to more sophisticated (and hopefully adult-oriented) robots you’re more likely to buy.

Editor’s note: This article originally appeared on Engadget.

Source Link A Chinese EV startup wants to build a ridable robot unicorn for kids

David Barret
David Barret

Related posts:

  1. US Health Officials Favor Covid Booster Shots To All Americans As Delta Variant Cases Rise
  2. Russian editor decries ‘destruction of media’ before election
  3. Daimler expects Mercedes Q3 sales significantly below Q2 – report
  4. Motor racing-Bottas rules out imminent announcement on his F1 future

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • How Forensic Scientists Are Reconstructing Faces Using DNA Found At Crime Scenes
  • New Non-Invasive Option For Treating Non-Melanoma Skin Cancer In A Single Session
  • Evolution Running Backwards? That’s What This Unlikely Organism Appears To Be Doing
  • How Did The Starfish Become A Star? 500-Million-Year-Old Fossil Solves Evolutionary Mystery
  • JWST Has Discovered Its First Exoplanet – And It’s A Baby Saturn-Sized One!
  • Rare “Moonwalking” Killer Whale Behavior Hides Much More Gory Truth
  • Dead Pulsars Are Emitting Radio Waves. Massive “Mountains” Measuring 1 Centimeter Tall Could Be To Blame
  • 40,000-Year-Old Mammoth Ivory Boomerang And Human Finger Hint At Mysterious Prehistoric Rituals
  • 99-Million-Year-Old Amber Fossils Mark The Oldest Known Example Of “Zombie Fungus” Infection
  • Breakthrough Qubit Control Near Absolute Zero Is Scalability Game-Changer For Quantum Computing
  • “On A Timescale Of Millions Of Years”: Scientists Detect Pulsing “Heartbeat” Under Africa
  • Skin Moles: What Are They And When Should You Get Them Checked?
  • 20 New Bat Viruses – Some “Cousins” Of Deadly Hendra And Nipah – Spark Fears Of Human Disease
  • “Nobody Expected This”: Earth’s Rotation Will Speed Up In July And August, Bucking The Downward Trend
  • What Is The “Heat Dome” Causing Baking Temperatures In The Eastern US This June?
  • Over 500 Bird Species At Risk In Next Century As We Face “Unprecedented” Extinction Crisis
  • World First: Mice With 2 Dads Father Their Own Offspring
  • Largest Ever Space-Based Gravitational Wave Observatory Begins Construction
  • Plastic Trash? This Bacterium Can Turn It Into Paracetamol – AKA Tylenol®
  • What Is The Earliest Evidence For Blue Eyes In Humans?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version